Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited
- PMID: 19249675
 - DOI: 10.1016/j.ccr.2009.02.007
 
VSports注册入口 - Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited
Abstract
Clinical practice reveals that therapy with angiogenesis inhibitors often does not prolong survival of cancer patients for more than months, because tumors elicit evasive resistance VSports手机版. In this issue of Cancer Cell, two papers report that VEGF inhibitors reduce primary tumor growth but promote tumor invasiveness and metastasis. These perplexing findings help to explain resistance to these drugs but raise pertinent questions of how to best treat cancer patients with antiangiogenic medicine in the future. We discuss here how VEGF inhibitors can induce such divergent effects on primary tumor growth and metastasis. .
Comment on
- 
  
  Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis.Cancer Cell. 2009 Mar 3;15(3):220-31. doi: 10.1016/j.ccr.2009.01.027. Cancer Cell. 2009. PMID: 19249680 Free PMC article.
 - 
  
  Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.Cancer Cell. 2009 Mar 3;15(3):232-9. doi: 10.1016/j.ccr.2009.01.021. Cancer Cell. 2009. PMID: 19249681 Free PMC article.
 
Publication types
- "V体育平台登录" Actions
 
MeSH terms
- VSports app下载 - Actions
 - "VSports app下载" Actions
 - V体育安卓版 - Actions
 
V体育官网入口 - Substances
- Actions (VSports app下载)
 
LinkOut - more resources
Full Text Sources (V体育2025版)
Other Literature Sources
